RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Harvard Bioscience - Stock

Harvard Bioscience Net Income 2024

Harvard Bioscience Net Income

8.64 M USD

Ticker

HBIO

ISIN

US4169061052

WKN

578107

In 2024, Harvard Bioscience's profit amounted to 8.64 M USD, a -352.95% increase from the -3.42 M USD profit recorded in the previous year.

The Harvard Bioscience Net Income history

YEARNET INCOME (undefined USD)
2026e15.5
2025e12.63
2024e8.64
2023-3.42
2022-9.5
2021-0.3
2020-7.8
2019-4.7
2018-2.9
2017-0.9
2016-4.3
2015-19
20142.4
2013-1.8
20122.4
20113.8
201019
20097.2
20081.7
2007-1.4
2006-2.3
2005-31.9
20042.3

Harvard Bioscience Aktienanalyse

What does Harvard Bioscience do?

Harvard Bioscience Inc was founded in 1901 and is headquartered in Holliston, Massachusetts. The company is a global leader in providing instruments, technologies, and complete systems for science and research. Harvard Bioscience has established itself as one of the leading providers of products and solutions in the fields of life sciences and health research with over 100 years of industry experience. The business model of Harvard Bioscience is focused on delivering high-quality products and solutions for research needs. The company is divided into three business segments: Life Science Research Products, Preclinical Surgical Products, and Analytical Instruments. These business segments offer a variety of products, such as instruments for cell and molecular research, gene expression analysis devices, surgical instruments, and instruments for electrophysiology. The Life Science Research segment includes the business units Harvard Apparatus, Molecular Devices, and Denville Scientific. Harvard Apparatus provides instruments for cell and molecular research, physiological instruments, and animal model systems. Molecular Devices specializes in instrumental analysis methods for cell and molecular research. Denville Scientific is a leading supplier of products for cell and molecular biology, including materials for gene and protein expression and cell culture techniques. In the Preclinical Surgical Products segment, Harvard Bioscience operates with the company Hugo Sachs Elektronik. Surgical instruments and complete systems for preclinical research are offered here. These products are popular among scientists worldwide as they have been developed for conducting research with animal models. Analytical Instruments is the segment where the company operates joint ventures to develop instruments for physical, material, and life science research. In this segment, Harvard Bioscience is primarily involved in the joint venture Wasatch Microfluidics, alongside Agilent Technologies, which specializes in the development of instruments for life sciences and biotechnology. As a provider of science and research-related instruments and devices, Harvard Bioscience has a wide range of products to help researchers and scientists enhance their work more effectively. Some of the most popular products from Harvard Bioscience include tissue processing systems, neuroprotection applications, animal model holders, and electrophysiology platforms. Harvard Bioscience also offers a range of products for quality assurance and environmental protection, such as cleanroom and protection devices for material preparation and sterilization. Overall, Harvard Bioscience Inc has an excellent reputation in the industry and is one of the world's leading companies for scientific and research-related products and services. The company constantly strives to improve its products and services and adapts to the needs of its customers. It relies on innovation and continuously works to develop and implement new technologies to meet the demands of the scientific world. Harvard Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Harvard Bioscience's Profit Margins

The profit margins of Harvard Bioscience represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Harvard Bioscience's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Harvard Bioscience's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Harvard Bioscience's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Harvard Bioscience’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Harvard Bioscience Stock

How much profit has Harvard Bioscience made this year?

Harvard Bioscience has made 8.64 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -352.95% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Harvard Bioscience publish its earnings?

Harvard Bioscience publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Harvard Bioscience?

The profits of Harvard Bioscience are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Harvard Bioscience?

You can learn more about the earnings of Harvard Bioscience by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Harvard Bioscience pay?

Over the past 12 months, Harvard Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Harvard Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Harvard Bioscience?

The current dividend yield of Harvard Bioscience is .

When does Harvard Bioscience pay dividends?

Harvard Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Harvard Bioscience?

Harvard Bioscience paid dividends every year for the past 0 years.

What is the dividend of Harvard Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Harvard Bioscience located?

Harvard Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Harvard Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Harvard Bioscience from 6/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/11/2024.

When did Harvard Bioscience pay the last dividend?

The last dividend was paid out on 6/11/2024.

What was the dividend of Harvard Bioscience in the year 2023?

In the year 2023, Harvard Bioscience distributed 0 USD as dividends.

In which currency does Harvard Bioscience pay out the dividend?

The dividends of Harvard Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Harvard Bioscience stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Harvard Bioscience

Our stock analysis for Harvard Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Harvard Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.